Diversified pharmaceutical and life sciences outsourced services provider
|Date of initial investment||August 2023|
PharmAlliance is a diversified pharmaceutical and life sciences services provider focused on discovery, development, and commercialization solutions across the drug life cycle to emerging and established pharmaceutical, biotechnology, life sciences, and medical device companies. In conjunction with its formation, PharmAlliance made an initial investment in BioBridges, a leading drug development consulting business serving emerging and mid-sized pharmaceutical sponsors and biotechnology companies.
We believe BioBridges is an exceptional entry point from which to create a sector-leading business in the large, growing, and fragmented pharma services market. I could not be more pleased with the outcome and the support received from Waud Capital throughout this process. I am excited to continue building the company's core business while capitalizing on transformational growth opportunities.